Elekta (EKTA B) Stock Overview
A medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
EKTA B Community Fair Values
Create NarrativeSee what 18 others think this stock is worth. Follow their fair value or set your own to get alerts.
Elekta AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 58.50 |
| 52 Week High | SEK 67.65 |
| 52 Week Low | SEK 40.64 |
| Beta | 1.06 |
| 1 Month Change | 19.78% |
| 3 Month Change | 24.36% |
| 1 Year Change | -8.74% |
| 3 Year Change | -7.41% |
| 5 Year Change | -46.84% |
| Change since IPO | 328.05% |
Recent News & Updates
We Think Elekta (STO:EKTA B) Is Taking Some Risk With Its Debt
Nov 15
What Is Elekta AB (publ)'s (STO:EKTA B) Share Price Doing?
Oct 31Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20
Oct 06Recent updates
We Think Elekta (STO:EKTA B) Is Taking Some Risk With Its Debt
Nov 15What Is Elekta AB (publ)'s (STO:EKTA B) Share Price Doing?
Oct 31Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20
Oct 06Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20
Sep 15Elekta (STO:EKTA B) Is Paying Out A Dividend Of SEK1.20
Aug 28There's No Escaping Elekta AB (publ)'s (STO:EKTA B) Muted Revenues
Aug 19Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20
Aug 04Elekta (STO:EKTA B) Hasn't Managed To Accelerate Its Returns
Jul 25Is Now The Time To Look At Buying Elekta AB (publ) (STO:EKTA B)?
May 28Does Elekta (STO:EKTA B) Have A Healthy Balance Sheet?
Mar 19
AI-Powered Iris Technology Will Strengthen Future Prospects
Strong order growth and high book-to-bill ratio provide a solid foundation for future revenue and sales growth.Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20
Feb 27Earnings Miss: Elekta AB (publ) Missed EPS By 5.4% And Analysts Are Revising Their Forecasts
Feb 26Potential Upside For Elekta AB (publ) (STO:EKTA B) Not Without Risk
Feb 17Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20
Feb 03What Does Elekta AB (publ)'s (STO:EKTA B) Share Price Indicate?
Jan 17Elekta (STO:EKTA B) Is Paying Out A Dividend Of SEK1.20
Dec 23Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Nov 18We Think Elekta (STO:EKTA B) Is Taking Some Risk With Its Debt
Nov 15Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Nov 01Elekta AB (publ) (STO:EKTA B) Screens Well But There Might Be A Catch
Oct 09Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Sep 24Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20
Sep 09Should Shareholders Reconsider Elekta AB (publ)'s (STO:EKTA B) CEO Compensation Package?
Aug 30Elekta AB (publ)'s (STO:EKTA B) Intrinsic Value Is Potentially 81% Above Its Share Price
Aug 28Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20
Aug 15Elekta (STO:EKTA B) Hasn't Managed To Accelerate Its Returns
Jun 19What Elekta AB (publ)'s (STO:EKTA B) P/E Is Not Telling You
May 24Elekta AB (publ) (STO:EKTA B) Shares Could Be 29% Below Their Intrinsic Value Estimate
May 12When Should You Buy Elekta AB (publ) (STO:EKTA B)?
Apr 03Is Elekta (STO:EKTA B) A Risky Investment?
Mar 18Elekta (STO:EKTA B) Is Paying Out A Dividend Of SEK1.20
Feb 22Why Investors Shouldn't Be Surprised By Elekta AB (publ)'s (STO:EKTA B) P/E
Feb 20Return Trends At Elekta (STO:EKTA B) Aren't Appealing
Feb 08Elekta AB (publ)'s (STO:EKTA B) Intrinsic Value Is Potentially 37% Above Its Share Price
Jan 03Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Dec 18Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20
Dec 01Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20
Nov 11Elekta (STO:EKTA B) Has Some Way To Go To Become A Multi-Bagger
Nov 09Shareholder Returns
| EKTA B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 37.5% | 5.5% | 3.2% |
| 1Y | -8.7% | -20.8% | 4.9% |
Return vs Industry: EKTA B exceeded the Swedish Medical Equipment industry which returned -21.4% over the past year.
Return vs Market: EKTA B underperformed the Swedish Market which returned 4.7% over the past year.
Price Volatility
| EKTA B volatility | |
|---|---|
| EKTA B Average Weekly Movement | 8.1% |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in SE Market | 11.7% |
| 10% least volatile stocks in SE Market | 3.1% |
Stable Share Price: EKTA B has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: EKTA B's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1972 | 4,484 | Jakob Just-Bomholt | www.elekta.com |
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit, a gamma knife system; and Leksell GammaPlan, a treatment planning and management software, as well as Elekta ONE, an oncology software suite.
Elekta AB (publ) Fundamentals Summary
| EKTA B fundamental statistics | |
|---|---|
| Market cap | SEK 22.35b |
| Earnings (TTM) | SEK 292.00m |
| Revenue (TTM) | SEK 17.57b |
Is EKTA B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EKTA B income statement (TTM) | |
|---|---|
| Revenue | SEK 17.57b |
| Cost of Revenue | SEK 10.86b |
| Gross Profit | SEK 6.71b |
| Other Expenses | SEK 6.41b |
| Earnings | SEK 292.00m |
Last Reported Earnings
Oct 31, 2025
Next Earnings Date
Mar 05, 2026
| Earnings per share (EPS) | 0.76 |
| Gross Margin | 38.17% |
| Net Profit Margin | 1.66% |
| Debt/Equity Ratio | 76.7% |
How did EKTA B perform over the long term?
See historical performance and comparisonDividends
Does EKTA B pay a reliable dividends?
See EKTA B dividend history and benchmarks| Elekta dividend dates | |
|---|---|
| Ex Dividend Date | Mar 05 2026 |
| Dividend Pay Date | Mar 11 2026 |
| Days until Ex dividend | 97 days |
| Days until Dividend pay date | 103 days |
Does EKTA B pay a reliable dividends?
See EKTA B dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/27 00:32 |
| End of Day Share Price | 2025/11/27 00:00 |
| Earnings | 2025/10/31 |
| Annual Earnings | 2025/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Elekta AB (publ) is covered by 30 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Alexander Kleban | Barclays |
| Sally Taylor | Barclays |